{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-020295","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2025-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.896263+00:00","generated_at":"2026-05-18T04:59:01.384376+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Dare Bioscience raises $16.5M, believes it regains Nasdaq equity compliance","bullets":["Raised approx. $16.5M gross from ATM and equity line sales since Mar 31, 2025.","Believes stockholders' equity now exceeds $2.5M Nasdaq minimum for continued listing.","Will notify Nasdaq; no guarantee of regaining compliance.","Shares outstanding will be ~12.6M after the sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-020295","json":"https://secwatch.observer/filing/0001641172-25-020295.json","markdown":"https://secwatch.observer/filing/0001641172-25-020295.md","text":"https://secwatch.observer/filing/0001641172-25-020295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225020295/0001641172-25-020295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225020295/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:59:01.384376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}